for predicting long-term mortality in patients with cardiovascular diseases. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In patients with advanced heart failure (HF), an elevated NLR is a negative prognostic marker of short-and long--term mortality. 15, 16 However, data regarding the prognostic value of the NLR among patients with ischemic or nonischemic HF are lacking.
Polish citizens. Insured patients were marked as alive. Complete follow-up data were available for the whole study cohort. statistical analysis Continuous variables were described as mean and standard deviation or median with interquartile range. Categorical variables were expressed as frequencies and percentages. The assumption of normality for continuous variables was verified by the Shapiro-Wilk test. Continuous variables were compared across the NLR tertiles with the analysis of variance or the Kruskal-Wallis test, which are appropriate for categorical variables, and were compared with the χ 2 test.
The Kaplan-Meier method with log-rank testing was used to compare survival probability between the NLR tertiles. Univariate and multivariate Cox regression models were used to evaluate the association between the NLR tertiles and mortality. The stepwise selection method of model building was used, with a P value set to 0.2 to allow a confounder into the model, and a P value set to 0.1 for a confounder to stay in the model. Crude and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were presented. The interpretation of statistical significance was based on an α value of 0.05. Statistical analyses were performed using the SAS statistical software package, version 9.4 (SAS Institute Inc., Cary, North Carolina, United States) and the STATIS-TICA 10 software (StarSoft Inc., Tulsa, Oklahoma, United States).
results The study sample consisted of a cohort of 1734 patients with systolic HF (1387 men), with a median age of 61 years (interquartile range, 53-71 years). The baseline characteristics of patients across the NLR tertiles are listed in tAble 1.
The ischemic etiology of HF was diagnosed in about 65% of patients across the NLR tertiles. There was a stepwise relationship between NLR intervals and comorbidities in the whole group. Patients in the highest NLR tertile were significantly older and more often had diabetes, anemia, atrial fibrillation, and at least stage III of chronic kidney disease. They also had a higher New York Heart Association functional class on admission, lower LVEF and left ventricular enddiastolic volume, and more often had significant valvular disease compared with patients in the low NLR tertile.
Laboratory findings revealed a stepwise relationship between hemoglobin concentrations, white blood cell count, bilirubin, blood urea nitrogen, creatinine, uric acid, and N-terminal pro-B-type natriuretic peptide. According to admission laboratory status, patients in the third NLR tertile had significantly lower hemoglobin levels, higher white blood cell count, bilirubin, blood urea nitrogen, creatinine, and uric acid values when compared with patients in the first tertile.
There were some significant differences between the NLR tertile subgroups in the prescribed treatment at hospital discharge. Patients in the The present study was undertaken to investigate the relation between the NLR on admission and long-term all-cause mortality in a large cohort of patients with a left ventricular ejection fraction (LVEF) of 35% or lower. The second objective was to establish whether the NLR has the same prognostic value in patients with ischemic and nonischemic HF.
PAtIents And methods
The cohort analyzed in this study was a subset of the population from the prospective Contemporary Modalities in Treatment of Heart Failure registry (COMMIT-HF, ClinicalTrials.gov Identifier: NCT02536443), which is currently ongoing at the 3rd Department of Cardiology of the Silesian Center for Heart Diseases in Zabrze, Poland. The COMMIT-HF is a registry of a broad, unselected patient population admitted to our institution, with a LVEF of 35% or lower, with the exclusion of patients with acute coronary syndromes. The baseline characteristics of patients and in-hospital data were recorded on case report forms. In this database, information on demographic data, concomitant diseases, and laboratory parameters, such as neutrophil and leukocyte counts, are stored. All patients underwent LVEF assessment in the first 24 hours of admission. Patients with medical conditions or treatments known to affect the white blood cell count, such as disorders of the hematopoietic system, cancer, chronic or acute infection, and glucocorticoid therapy, were excluded from the study. We analyzed a total of 1734 consecutive patients who had been treated at our institution between January 2009 and December 2013.
There is still no consensus on the cut-off points to define the levels of the NLR 17 ; therefore, patients were divided into tertiles based on admission NLR values. The first (low), second (medium), and third (high) tertiles were defined as NLR ≤2.04 (n = 578), NLR 2.05-3.1 (n = 578), and NLR >3.1 (n = 578), respectively. A survival analysis, stratified by the NLR tertile, was used to evaluate the predictive value of the NLR in the whole cohort and separately for patients with ischemic and nonischemic HF. The ischemic etiology of HF was established in patients with a history of myocardial infarction, percutaneous coronary interventions, coronary artery bypass grafting, or with multi-vessel coronary artery disease diagnosed by means of coronary angiography in the absence of concomitant underlying causes of HF. The study was approved by an institutional review board at the Regional Medical Chamber.
Leukocyte and neutrophil counts were determined using an automated Sysmex XS1000i hematology analyser (Sysmex Corporation, Kobe, Japan). The NLR was calculated as the ratio of neutrophil cell count to lymphocyte cell count, obtained from blood samples drawn in fasting state.
Information on survival was based on the National Health Fund insurance status, which can be electronically verified as the National Health Fund insurance policy that is obligatory for all Cox regression analysis revealed that in the whole study population, the third NLR tertile was an independent factor related to higher long-term mortality (HR, 1.43; 95% CI, 1.10-1.85; P = 0.006), along with older age, higher heart rate on admission, diabetes, chronic kidney disease, severe mitral insufficiency, and higher red cell distribution width (RDW) value. Higher LVEF, as well as administration of angiotensin-converting enzyme inhibitors and β-blockers were shown to improve survival (FIGure 1). FIGure 2 shows the Kaplan-Meier curves for the overall survival in months across the NLR tertiles in the whole study group. The Kaplan-Meier analysis of the subpopulation with ischemic HF revealed significant differences in survival between the NLR tertiles, as shown in FIGure 3. This was also reflected in the multivariate analysis, where the third NLR tertile was an independent factor related to higher third tertile, compared with those in the first tertile, were less frequently treated with statins, β-blockers, aldosterone blockers, angiotensin--converting enzyme inhibitors, or angiotensin receptor antagonists. Patients in the highest tertile were more often on insulin therapy.
Follow-up data were available for the whole cohort. A median follow-up duration was 660 days (interquartile range, 331-1074 days). The primary endpoint was all-cause mortality. During the follow-up period, 443 deaths were reported. There was an almost 3-fold increase in all-cause 12-month mortality in the group of patients with NLR values within the third tertile compared with those in the first tertile (7.61% vs 20.07%; P <0.001).
The HR of the long-term all-cause mortality was significant both in the second (HR, 1.37; 95% CI, 1.06-1.77; P = 0.014) and the third NLR tertile (HR, 2.31; 95% CI, 1.82-2.92; P <0.0001). The FIGure 1 Predictors of mortality in the whole study group Abbreviations: CI, confidence interval; HR, hazard ratio; ICD, implantable-cardioverter defibrillator; RDW, red cell distribution width; others, see tAble 1 FIGure 2 Kaplan--Meier curves comparing 12-month survival across neutrophil-to-lymphocyte ratio (NLR) tertiles in the whole study group values within the third tertile compared with the first tertile (7.61% vs 20.07%, P <0.001). Second, the high NLR tertile was associated independently with an increased risk of long-term all--cause mortality only in the subpopulation of patients with LVEF of 35% or lower with ischemic etiology, whereas in participants with nonischemic HF, after adjusting for potential confounding factors, there was no independent relation between the NLR tertile and mortality. In this subpopulation, the only factors independently impairing 12-month survival were severe mitral insufficiency, severe aortic valve disease, diabetes mellitus, and higher RDW value. The NLR calculated on the basis of a complete blood count with differential test results is an inexpensive and easily obtainable marker of inflammation. Numerous studies have demonstrated that an increased neutrophil count might reflect inflammation and that lymphopenia is an indicator of physiologic stress. Both parameters long-term mortality (HR, 1.51; 95% CI, 1.11-2.04; P = 0.008; FIGure 4).
In the nonischemic HF group, the Kaplan--Meier analysis also revealed significant differences in survival between the NLR tertiles ( FIGure 5) ; however, the influence of the NLR on long-term survival was not confirmed after adjusting for prognostic covariates with multivariable Cox proportional models (FIGure 6). In this population, the factors that independently impaired long--term survival were the presence of severe mitral insufficiency, severe aortic valve disease, diabetes mellitus, and higher RDW value. Higher LVEF and β-blocker administration were identified to have protective effect. dIscussIon There were 2 major findings of this study regarding patients with LVEF of 35% or lower. First, in the whole study population there was an almost 3-fold increase in mortality during 12-month follow-up among patients with NLR Gensini scores. [28] [29] [30] [31] [32] [33] Additionally, the presence of arterial stiffness and coronary calcium score affect long-term prognosis. 34 Therefore, we hypothesize that low-grade systemic inflammation may affect the outcome of patients with HF through acceleration of coronary artery disease, but not through direct progressive myocardial injury from inflammatory mediators.
5-7 However, this particular issue was out of scope of the study, and further research is required in this field.
Earlier studies have shown that in patients with advanced decompensated HF, an elevated NLR is associated with increased long-term risk of mortality; however, those studies did not analyze HF etiology. 16, 17 In a retrospective analysis of the Studies Of Left Ventricular Dysfunction (SOLVD), an increased risk of death was associated with elevated white blood cell count, but the relationship was limited only to participants with cardiomyopathy of ischemic origin.
35
Our study extends the results of the previous reports. To the best of our knowledge, this is the first study to comprehensively assess the relation between the NLR and long-term prognosis in patients with ischemic and nonischemic HF. In have been associated with poor outcomes in patients with cardiovascular disease. However, the NLR has been shown to predict mortality more accurately than other absolute neutrophil or lymphocyte counts.
18-22
The post hoc analysis of the National Health and Nutrition Examination Survey-III (1988 --1994 , including subjects without coronary heart disease, revealed that the NLR can independently predict cardiovascular mortality in an asymptomatic general population. 23 The NLR has been analyzed in numerous studies. It has been associated with poor clinical outcome in various cardiac diseases, including stable coronary artery disease as well as acute coronary syndromes.
24,25 A metaanalysis of 10 cohort studies provided evidence that the NLR is a negative predictor of all-cause mortality in patients undergoing coronary angiography or invasive revascularization, including coronary artery bypass grafting. 26,27 These unfavorable outcomes in patients with coronary artery disease can be attributed to observations indicating that the ratio is an independent predictor of both the extent and the complexity of coronary artery disease graded by the SYNTAX and conclusion, we found that the NLR measured on admission may provide valuable information on risk stratification in patients with a LVEF of 35% or lower in a subgroup of patients with ischemic HF. In our large cohort of patients, the NLR was an independent long-term prognostic risk factor. study limitations This study has several limitations. It was a single-center observational study derived from a real-world practice. We used a single blood sample to calculate the NLR and included all-cause mortality as our endpoint. Nonetheless, potential disadvantages of the retrospective analysis are diminished by the fact that patients' data were input into a computer database by the attending physician upon the patient's admission to our center. Strengths of this study include a large patient cohort, detailed data on clinical, echocardiographic, and laboratory parameters, as well as a long follow-up period. Considering the retrospective character of our analysis, the results should be regarded as hypothesis-generating and need to be confirmed in prospective trials.
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